137 related articles for article (PubMed ID: 3301895)
1. Kinetics study of immunological response to Clostridium botulinum toxin.
Dezfulian M; Bitar RA; Bartlett JG
J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
[TBL] [Abstract][Full Text] [Related]
2. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
Hörmeyer E; Schultz A; Sailer J; Opitz G; Stünkel K; Petzoldt K
Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):16-9. PubMed ID: 3885940
[No Abstract] [Full Text] [Related]
3. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
Dezfulian M; Bartlett JG
J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
[TBL] [Abstract][Full Text] [Related]
4. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
Keller JE
Clin Vaccine Immunol; 2008 Sep; 15(9):1374-9. PubMed ID: 18667637
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.
Held DM; Shurtleff AC; Fields S; Green C; Fong J; Jones RG; Sesardic D; Buelow R; Burke RL
Clin Vaccine Immunol; 2010 Jun; 17(6):930-6. PubMed ID: 20410329
[TBL] [Abstract][Full Text] [Related]
6. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
Ligieza J; Reiss J; Michalik M
Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
[TBL] [Abstract][Full Text] [Related]
7. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
Dezfulian M; Bartlett JG
Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
Pittman PR; Hack D; Mangiafico J; Gibbs P; McKee KT; Friedlander AM; Sjogren MH
Vaccine; 2002 May; 20(16):2107-15. PubMed ID: 11972980
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.
Doellgast GJ; Triscott MX; Beard GA; Bottoms JD
J Clin Microbiol; 1994 Mar; 32(3):851-3. PubMed ID: 8195408
[TBL] [Abstract][Full Text] [Related]
10. An improved method for development of toxoid vaccines and antitoxins.
Jones RG; Liu Y; Rigsby P; Sesardic D
J Immunol Methods; 2008 Aug; 337(1):42-8. PubMed ID: 18571196
[TBL] [Abstract][Full Text] [Related]
11. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
Dezfulian M; Bartlett JG
Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
[TBL] [Abstract][Full Text] [Related]
12. Clostridium botulinum subtype Ba.
Giménez DF
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
[TBL] [Abstract][Full Text] [Related]
13. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
Hatheway CL
Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.
Siegel LS
J Clin Microbiol; 1989 Aug; 27(8):1906-8. PubMed ID: 2768475
[TBL] [Abstract][Full Text] [Related]
15. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
Notermans S; Dufrenne J; Kozaki S
Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
[TBL] [Abstract][Full Text] [Related]
16. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
[TBL] [Abstract][Full Text] [Related]
17. [Toxoids of botulinum toxin type G].
Puig de Centorbi ON; Ciccarelli AS; Giménez DF
Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
[TBL] [Abstract][Full Text] [Related]
18. The antibody response of cattle to Clostridium botulinum types C and D toxoids.
Jansen BC; Knoetze PC; Visser F
Onderstepoort J Vet Res; 1976 Dec; 43(4):165-73. PubMed ID: 799279
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
[TBL] [Abstract][Full Text] [Related]
20. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay.
Siegel LS
J Clin Microbiol; 1988 Nov; 26(11):2351-6. PubMed ID: 3235662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
